Assessment of Erlotinib as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Patients
Crossref DOI link: https://doi.org/10.1245/s10434-014-3878-0
Published Online: 2014-07-08
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosenthal, Eben L.
Chung, Thomas K.
Carroll, William R.
Clemons, Lisa
Desmond, Renee
Nabell, Lisle
Text and Data Mining valid from 2014-07-08